WEDERM Co., Ltd. is a Seoul-based medical aesthetics company founded in 2021, developing and exporting HA fillers, botulinum toxin, skin boosters, and lipolysis solutions under its own brand AETERDERM. WEDERM manages the full cycle from R&D to manufacturing and branding, and exports to around 30 countries across Asia, Russia/CIS, Europe, and the Americas.

At IMCAS World 2027, WEDERM presents AETERDERM PURIHILO PN, a hybrid skin booster combining 40 mg high-molecular HA and 40 mg low-molecular HA with 25 mg polynucleotide in a 2.5 mL syringe. Stabilized through the PCT-patented ABEP acid-base equilibrium process, it binds HA without BDDE or heat treatment, preserving ingredient integrity and eliminating cross-linker-related side effects. Fewer injection points, less discomfort, deep hydration from HA, and skin regeneration and elasticity from PN.

Visit our booth to discover the AETERDERM PURI line.